Are the new quinolones appropriate treatment for community-acquired methicillin-resistant Staphylococcus aureus?

International Journal of Antimicrobial Agents
Bo ShopsinKarl Drlica

Abstract

The use of quinolones in the treatment of non-serious community-acquired methicillin-resistant Staphylococcus aureus is discussed. The new C8-modified quinolones may be suitable for such treatment but controlled trials should be carried out to ensure that the pharmacokinetics are such that there is little risk of resistance developing.

References

Jun 1, 1991·The Journal of Infectious Diseases·H M BlumbergI K Wachsmuth
Aug 11, 1998·The Journal of Infectious Diseases·P M AdcockT V Murphy
Nov 26, 1999·The Pediatric Infectious Disease Journal·A L FrankP C Schreckenberger
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E J GorakJ D Brown
Jun 20, 2000·Antimicrobial Agents and Chemotherapy·J L Martinez, F Baquero
Nov 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S HarbarthD Pittet
Mar 15, 2001·Diagnostic Microbiology and Infectious Disease·R N JonesUNKNOWN SENTRY Antimicrobial Surveillance Program Participants Group
Aug 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·X Zhao, K Drlica
Aug 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B R Levin
Oct 16, 2001·Antimicrobial Agents and Chemotherapy·L F DiscottoJ F Barrett
Oct 27, 2001·The Journal of Antimicrobial Chemotherapy·J Fung-TomcE Gradelski
Dec 26, 2001·The Journal of Antimicrobial Chemotherapy·T M A WellerR Wise
Jan 31, 2002·American Journal of Clinical Dermatology·Joseph M Blondeau
Aug 17, 2002·The Pediatric Infectious Disease Journal·Arthur L FrankJohn P Quinn
Nov 1, 2002·Journal of Clinical Microbiology·Keiko OkumaKeiichi Hiramatsu
Jan 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cassandra D SalgadoDavid P Calfee
Jun 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Bo ShopsinBarry N Kreiswirth
Oct 30, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lisa SaimanPhyllis Della-Latta
Oct 30, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Erica S PanFrançoise Perdreau-Remington

❮ Previous
Next ❯

Citations

Feb 2, 2006·Current Infectious Disease Reports·Matthew E Levison, Shirley Fung
Feb 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stan Deresinski
Oct 12, 2010·The Journal of Antimicrobial Chemotherapy·Matthew S Dryden
Oct 17, 2007·Antimicrobial Agents and Chemotherapy·Kazuki HoshinoTsuyoshi Otani
Oct 26, 2012·Interdisciplinary Perspectives on Infectious Diseases·Axel Dalhoff
Jan 21, 2006·International Journal of Antimicrobial Agents·Helen C Maltezou, Helen Giamarellou
Jun 1, 2006·The Annals of Pharmacotherapy·Kathryn E SabolJames S Lewis
Jan 11, 2005·Current Opinion in Infectious Diseases·Gregory M Anstead, Aaron D Owens
Nov 1, 2005·Current Opinion in Infectious Diseases·Michael W Ellis, James S Lewis
May 11, 2011·Neuropsychological Rehabilitation·Jennifer D RyanCarolyn M Baum
Mar 16, 2007·Expert Opinion on Emerging Drugs·Emma J Bishop, Benjamin P Howden

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.